CBT
NYECabot Corporation
Basic Materials•Specialty Chemicals
Watchlists:
Last updated: Sunday 20th July 2025
74.90
-1.36 (-1.78%)
Prev Close:76.26
Open:76.7
Bid:74.51
Ask:75.35
52 Week Range
71.64117.46
Volume:409,918
Mkt Cap:4,093 M
59
MarketXLS Rank ®
Hold
Price Target
$86.14
+15.0%
Financial Statements
CBT - Income Statement (Annual)
| Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 | Sep-15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Accrued Preferred Stock Dividends | 1000000.0 | 1000000.0 | 1000000.0 | |||||||
| Basic Discontinuous Operations | 0.02 | 0.02 | ||||||||
| Depreciation And Amortization | 151 M | 144 M | 146 M | 160 M | 158 M | 148 M | -149 M | -155 M | -161 M | -183 M |
| Diluted Discontinuous Operations | 0.02 | 0.02 | ||||||||
| Earnings From Equity Interest | 6 M | 5 M | 10 M | 3 M | 3 M | 1000000.0 | 2 M | 7 M | 3 M | 4 M |
| Earnings From Equity Interest Net Of Tax | 6 M | 5 M | 10 M | 3 M | 3 M | 1000000.0 | 2 M | 7 M | 3 M | 4 M |
| Gain On Sale Of Business | 24 M | |||||||||
| Gain On Sale Of Security | 10 M | -17 M | ||||||||
| Gains Loss On Disposal Of Discontinued Operations | 1000000.0 | 2 M | ||||||||
| General And Administrative Expense | 283 M | 253 M | 258 M | 289 M | 292 M | 290 M | -32 M | -33 M | -31 M | -29 M |
| Gross Profit Margin (profit Margin After CGS) | 960 M | 839 M | 885 M | 799 M | 500 M | 685 M | 772 M | 663 M | 578 M | 585 M |
| Impairment Of Capital Assets | 3 M | 207 M | 29 M | 92 M | 352 M | |||||
| Interest Expense Non Operating | 81 M | 90 M | 56 M | 49 M | 53 M | 59 M | 54 M | 53 M | 54 M | 53 M |
| Minority Interests | -44 M | -39 M | -34 M | -36 M | -17 M | -29 M | -39 M | -25 M | -15 M | -8 M |
| Misc Other Special Charges | -4 M | 15 M | 2 M | 1000000.0 | -1000000.0 | 8 M | 27 M | 5 M | -2 M | -7 M |
| Net Income (loss) | 380 M | 445 M | 209 M | 250 M | -238 M | 157 M | -113 M | 248 M | 126 M | -334 M |
| Net Income Common Stockholders | 380 M | 445 M | 206 M | 247 M | -238 M | 186 M | -113 M | 248 M | 126 M | -334 M |
| Net Income Continuous Operations | 424 M | 484 M | 243 M | 250 M | -238 M | 157 M | -113 M | 248 M | 126 M | -334 M |
| Net Income Discontinuous Operations | 1000000.0 | 2 M | ||||||||
| Net Non Operating Interest Income Expense | -81 M | -90 M | 45 M | -49 M | -53 M | -59 M | -54 M | -53 M | -54 M | -53 M |
| Non Recurring Operation Expense | -9 M | |||||||||
| Normalized Income | 537 M | |||||||||
| Operating Income | 614 M | 526 M | 389 M | 454 M | 21 M | 306 M | 398 M | 347 M | 250 M | 245 M |
| Operating Income Before Depreciation (EBITDA) | 767 M | 690 M | 547 M | 615 M | 178 M | 462 M | 320 M | 507 M | 409 M | -141 M |
| Operating Expense | 346 M | 310 M | 313 M | 345 M | 349 M | 350 M | 374 M | 316 M | 328 M | 340 M |
| Other Gand A | 283 M | 253 M | 258 M | 289 M | 292 M | 290 M | -32 M | -33 M | -31 M | -29 M |
| Other Impairment Of Capital Assets | 162 M | 23 M | 210 M | |||||||
| Other Operating Expenses | -1000000.0 | -1000000.0 | -138 M | -1000000.0 | -2 M | -2 M | -2 M | -2 M | -1000000.0 | |
| Other Taxes | 1000000.0 | -2 M | -1000000.0 | |||||||
| Otherunder Preferred Stock Dividend | 1000000.0 | 1000000.0 | 1000000.0 | -1000000.0 | ||||||
| Preferred Stock Dividends | 1000000.0 | 1000000.0 | 1000000.0 | -1000000.0 | ||||||
| Rent And Landing Fees | 27 M | -32 M | -33 M | -31 M | -29 M | |||||
| Research Expense | 63 M | 57 M | 55 M | 56 M | 57 M | 60 M | 66 M | 56 M | 53 M | 58 M |
| Restructring And Mn A Income | 13 M | 4 M | 11 M | 19 M | 16 M | -25 M | -21 M | |||
| Salaries And Wages | -2 M | -2 M | -1000000.0 | -1000000.0 | 9 M | -3 M | -22 M | -16 M | -17 M | -12 M |
| Selling And Marketing Expense | 308 M | 260 M | 275 M | 282 M | ||||||
| Selling Expense | 308 M | 260 M | 275 M | 282 M | ||||||
| Total Income Available For Interest Expense (EBIT) | 616 M | 546 M | 401 M | 455 M | 20 M | 314 M | 171 M | 352 M | 248 M | -324 M |
| Total Revenues | 3,994 M | 3,931 M | 4,321 M | 3,409 M | 2,614 M | 3,337 M | 3,242 M | 2,717 M | 2,411 M | 2,871 M |
| Total Expenses | 3,380 M | 3,402 M | 3,749 M | 2,955 M | 2,463 M | 3,002 M | -2,096 M | -1,738 M | -1,505 M | -1,946 M |
| Total Revenue | 3,994 M | 3,931 M | 4,321 M | 3,409 M | 2,614 M | 3,337 M | 3,242 M | 2,717 M | 2,411 M | 2,871 M |
| Amord | 133 M | 134 M | 129 M | 140 M | 134 M | 90 M | ||||
| Avgshs | 55 M | 56 M | 57 M | 57 M | 57 M | 59 M | 62 M | 62 M | 62 M | 63 M |
| Avgshsdt | 56 M | 57 M | 57 M | 57 M | 57 M | 59 M | 62 M | 63 M | 63 M | 63 M |
| Basiceps | 6.79 | 7.79 | 3.65 | 4.35 | -4.21 | 2.64 | -1.85 | 3.94 | 2.38 | 0.64 |
| Basicepscont | 6.79 | 7.79 | 3.65 | 4.35 | -4.21 | 2.64 | -1.85 | 3.94 | 2.36 | -5.29 |
| Cor | 3,034 M | 3,092 M | 3,436 M | 2,610 M | 2,114 M | 2,652 M | -2,470 M | -2,054 M | -1,833 M | -2,286 M |
| Depamor | 151 M | 144 M | 146 M | 160 M | 158 M | 148 M | -149 M | -155 M | -161 M | -183 M |
| Dileps | 6.72 | 7.73 | 3.62 | 4.34 | -4.21 | 2.63 | -1.85 | 3.91 | 2.36 | 0.63 |
| Dilepscont | 6.72 | 7.73 | 3.62 | 4.34 | -4.21 | 2.63 | -1.85 | 3.91 | 2.34 | -5.29 |
| Div Per Share | 1.66 | 1.54 | 1.48 | 1.4 | 1.36 | 1.29 | 1.23 | 1.04 | 0.88 | |
| Netincdisc | 380 M | 445 M | 209 M | 250 M | -238 M | 157 M | -113 M | 248 M | 126 M | -334 M |
| Othincexp | -2 M | -20 M | -192 M | -4 M | -2 M | -9 M | 133 M | -12 M | 22 M | 213 M |
| Pretaxinc | 529 M | 451 M | 335 M | 406 M | -33 M | 255 M | 117 M | 299 M | 194 M | -377 M |
| Resdev | 63 M | 57 M | 55 M | 56 M | 57 M | 60 M | 66 M | 56 M | 53 M | 58 M |
| Restruct | 13 M | 4 M | 11 M | 19 M | 16 M | -25 M | -21 M | |||
| Sga | 283 M | 253 M | 258 M | 289 M | 292 M | 290 M | 308 M | 260 M | 275 M | 282 M |
| Shsout | 54 M | 55 M | 56 M | 57 M | 57 M | 57 M | 60 M | 62 M | 62 M | 63 M |
| Specincchg | -13 M | -3 M | -207 M | -11 M | -19 M | -16 M | -92 M | 25 M | -352 M | |
| Taxprov | 111 M | -28 M | 102 M | 123 M | 191 M | 70 M | 193 M | 33 M | 34 M | -45 M |